Evidence map›Paper›PMID 31052416›Full record

ArticleMolecules (Basel, Switzerland)2019

Deep-sea Hydrothermal Vent Bacteria as a Source of Glycosaminoglycan-Mimetic Exopolysaccharides.

Agata Zykwinska, Laëtitia Marchand, Sandrine Bonnetot, Corinne Sinquin, Sylvia Colliec-Jouault, Christine Delbarre-Ladrat

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Agata ZykwinskaIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Agata.Zykwinska@ifremer.fr.ORCID 0000-0001-7093-3832
Laëtitia MarchandIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Laetitia.Marchand@ifremer.fr.
Sandrine BonnetotIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Sandrine.Bonnetot@ifremer.fr.
Corinne SinquinIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Corinne.Sinquin@ifremer.fr.ORCID 0000-0002-8930-9535
Sylvia Colliec-JouaultIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Sylvia.Colliec.Jouault@ifremer.fr.ORCID 0000-0002-2449-5410
Christine Delbarre-LadratIFREMER, Laboratoire Ecosystèmes Microbiens et Molécules Marines pour les Biotechnologies, 44311 Nantes, France. Christine.Delbarre.Ladrat@ifremer.fr.

Funding

Agence Nationale de la Recherche ANR-17-CE08-0001
6 · The paper itself

Abstract

Bacteria have developed a unique strategy to survive in extreme environmental conditions through the synthesis of an extracellular polymeric matrix conferring upon the cells a protective microenvironment. The main structural component of this complex network constitutes high-molecular weight hydrophilic macromolecules, namely exopolysaccharides (EPS). EPS composition with the presence of particular chemical features may closely be related to the specific conditions in which bacteria evolve. Deep-sea hydrothermal vent bacteria have already been shown to produce EPS rich in hexosamines and uronic acids, frequently bearing some sulfate groups. Such a particular composition ensures interesting functional properties, including biological activities mimicking those known for glycosaminoglycans (GAG). The aim of the present study was to go further into the exploration of the deep-sea hydrothermal vent IFREMER (French Research Institute for Exploitation of the Sea) collection of bacteria to discover new strains able to excrete EPS endowed with GAG-like structural features. After the screening of our whole collection containing 692 strains, 38 bacteria have been selected for EPS production at the laboratory scale. EPS-producing strains were identified according to 16S rDNA phylogeny. Chemical characterization of the obtained EPS highlighted their high chemical diversity with the presence of atypical compositional patterns. These EPS constitute potential bioactives for a number of biomedical applications, including regenerative medicines and cancer treatment.

Indexed as

BacteriaDNA, BacterialDNA, RibosomalFranceHexosaminesHydrothermal VentsPhylogenyPolysaccharides, BacterialRNA, Ribosomal, 16SSeawaterSequence Analysis, DNAUronic AcidsDNA, BacterialDNA, RibosomalHexosaminesPolysaccharides, BacterialRNA, Ribosomal, 16SUronic Acidsexopolysaccharideglycosaminoglycanhexosaminephylogenetic analysisuronic acid

Identifiers

PMID31052416
PMCPMC6539532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.